Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Ryan S. Stolcpart, PharmD
Advertisement
Articles by Ryan S. Stolcpart, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Bridging Science and Reality in Diabetes Care
4
Nutrition in Pregnancy May Shape Metabolic Health After Delivery
5